For M. Chandramohan, Managing Director of Microcore Research Laboratories India Pvt Ltd, that mystery arrived not in a research paper or a conference hall, but at the breakfast table. He noticed that the idlis made by the elder women in his family turned out softer, lighter and better fermented than the ones made by the younger cooks, even when the rice, the lentils and the method looked identical on paper. Most people would have called it experience, or a grandmother's touch. Chandramohan called it a question worth answering. That single observation, chased with a young researcher's stubbornness, would eventually grow into a biotechnology company that today holds patents, clinical validations and a regulatory distinction no other Indian company in its category can claim. Two legends from that period left a lasting imprint. He speaks of Mr. Shri Kumar Suryanarayanan, Head and Director Biocon R&D under whom he worked in R&D, as a strategic mind who could connect deep scientific understanding with the practical demands of running a process floor. Someone who taught him that good biotechnology needs as much discipline as it does discovery. And in the organisation's departmental review meetings, he had the rare opportunity to observe Biocon Chair person Dr. Kiran Mazumdar Shaw at close range, watching how she moved fluidly between the language of science and the language of business. That back and forth, knowing when a scientific opportunity was worth chasing and when a promising idea needed to be tested against commercial reality, reshaped his own ambitions. He no longer wanted to sit on just one side of that divide. He wanted to be the kind of scientist who could carry an idea the entire distance, all from hypothesis to hospital shelf.
Microcore has been honored as a cover feature, highlighting our pioneering research-driven approach to product development and scientific excellence.
Special recognition for our commitment to high-potency manufacturing standards and innovative, clinically validated nutraceutical solutions.
Redefining India’s Position in Global Nutraceutical Innovation
India’s nutraceutical industry is witnessing unprecedented growth, fueled by rising preventive healthcare awareness, lifestyle disorders, aging populations, and increasing consumer focus on wellness.
https://theceoverse.com/iconic-leaders/m-chandramohan/
Clinically Validated Natural Egg Shell Membrane (NESM): A Paradigm Shift in Osteoarthritis Management through Biomaterial Innovation and Regenerative Nutraceutical Science
Top 10 Impactful Healthcare Companies Driving Regenerative Solutions - Inner review August 2026
Perhaps the most powerful dimension of Chandramohan’s story is his conviction that India's biotechnology future should
extend beyond manufacturing. He draws a deliberate distinction between “Make in India” and “Made in India.”
For him, true self‑reliance means owning the innovation itself developing intellectual property, conducting research, validating products clinically, meeting global quality standards, and creating technologies capable of competing internationally.
Microcore represents his attempt to demonstrate that this model is possible. From traditional fermentation practices that sparked his early scientific curiosity, to industrial biotechnology, consulting across more than 500 companies, the
systematic exploration of agricultural waste, and the development of patented natural eggshell membrane technology, Chandramohan’s journey has consistently revolved around one principle꞉ science becomes truly
meaningful when it can be translated into solutions that improve lives.
As Microcore moves toward regenerative healthcare, advanced delivery systems, novel biomaterials, and global expansion, its story is no longer simply about nutraceutical manufacturing. It is about building an India‑born, science‑led healthcare innovation ecosystem one capable of transforming indigenous biological resources into clinically validated technologies and, ultimately, contributing to a more evidence‑based, regenerative, and resilient future for healthcare.
Scientist reimagining Indias's future in Biotechnology
Microcore Research Labs India Pvt. Ltd. stands among a select group of global enterprises that uniquely integrate robust intellectual property, clinically substantiated research and stringent regulatory compliance within the nutraceutical and biomaterials domain.
Selected as a finalist in the Scientific Posture Competition organized by Medlab Asia and Asia Health 2024.
Media outlets covered the partnership to manufacture and distribute high-efficacy NESM supplements across India.
Honored as one of the Top 100 SMEs in India by SME FORUM INDIA at Taj Palace, New Delhi.
Entering a strategic partnership to develop novel Orthopedic formulations, leveraging large-scale manufacturing capabilities for global healthcare impact.
Recognized for clinically validated natural eggshell membrane formulations that offer a superior, safer alternative to diacerein-based drug combinations in joint care management.